Pharmaceuticals, Biotechnology and Life Sciences
Exscientia has made a deal to acquire GT Apeiron’s share of its oral CDK7 inhibitor programme, gaining full control of GTAEXS617 (‘617) and all related intellectual property, it said Thursday....
ProKidney Corp., a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease, today announced the pricing of an underwritten public offering and a concurrent registered direct offering of...
World Food Safety Day is jointly facilitated by the Food and Agriculture Organization of the United Nations (FAO) and the World Health Organization (WHO), and aims to draw attention and inspire action to help prevent, detect and manage foodborne risks,...
The society is changing rapidly, millennials are now 40 years old people, and it's OK. The Gen-X folks are already...
Because we've seen a lot of antivax narratives, let's just give you a brief history of immunization. A Journey Through...
All dollar amounts reflected in Canadian dollars unless otherwise stated.VANCOUVER, British Columbia, July 26, 2024 (GLOBE NEWSWIRE) — Rakovina Therapeutics…
PURCHASE, N.Y., July 26, 2024 (GLOBE NEWSWIRE) — Cognition Therapeutics, Inc. (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical stage…
HIGH POINT, N.C., July 26, 2024 (GLOBE NEWSWIRE) — vTv Therapeutics Inc. (Nasdaq: VTVT), a late stage biopharmaceutical company with…
Company to host conference call on Monday, July 29 at 8:30 a.m. ETNAARDEN, the Netherlands and MIAMI, July 26, 2024…
BOSTON, July 26, 2024 (GLOBE NEWSWIRE) — eLabNext, a leading provider of digital lab management solutions, and ABI-LAB, a premier life…
SHANGHAI, July 26, 2024 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading…
NEW YORK, July 26, 2024 (GLOBE NEWSWIRE) — Psyence Group Inc (“Psyence Group”) (CSE: PSYG), a life science biotechnology company…
Topline results demonstrated a favorable safety profile and tolerability across four ascending dose levels in healthy volunteers and showed dose…
$30.3 million financing upfront with up to an additional $92.4 million tied to exercise of warrants, with certain of the…
Presentation to feature Silo’s novel therapeutics for the underserved SARASOTA, FL, July 26, 2024 (GLOBE NEWSWIRE) — Silo Pharma, Inc.…
